{"id":76497,"date":"2026-10-21T18:15:19","date_gmt":"2026-10-21T18:15:19","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76497"},"modified":"2026-10-21T18:15:19","modified_gmt":"2026-10-21T18:15:19","slug":"us-analyst-updates-october-21st-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/","title":{"rendered":"US Analyst Updates: October 21st, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

Today\u2019s analyst updates suggest a selective outlook, with strength in defence, pharmaceuticals and parts of software and financial services. Technology remains divided, as upgrades and higher targets contrast with cuts across several semiconductor and cloud infrastructure names. Restaurants, autos and streaming attracted greater caution, while banks and utilities showed mixed revisions. Overall, the ratings favour individual opportunities rather than broad confidence across the market.<\/p>\n

Updates\u00a0 (391)<\/h3>\n

3M (MMM)<\/strong> \u2014 Bernstein maintained its Market Perform rating and raised its price target to US$197.00 from US$171.00.<\/p>\n

3M (MMM)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

3M (MMM)<\/strong> \u2014 Deutsche Bank maintained its Hold rating.<\/p>\n

3M (MMM)<\/strong> \u2014 Jefferies maintained its Hold rating and set a US$186.00 price target.<\/p>\n

3M (MMM)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$191.00 from US$185.00.<\/p>\n

3M (MMM)<\/strong> \u2014 Raymond James maintained its Market Perform rating.<\/p>\n

3M (MMM)<\/strong> \u2014 RBC Capital Markets maintained its Underperform rating and raised its price target to US$135.00 from US$132.00.<\/p>\n

3M (MMM)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

AbbVie (ABBV)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$325.00 from US$300.00.<\/p>\n

Abivax (ABVX)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

Abivax (ABVX)<\/strong> \u2014 Wedbush maintained its Neutral rating and lowered its price target to US$96.00 from US$118.00.<\/p>\n

Accenture (ACN)<\/strong> \u2014 Baird downgraded the stock to Neutral from Outperform and raised its price target to US$252.00 from US$245.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Susquehanna maintained its Positive rating and raised its price target to US$620.00 from US$550.00.<\/p>\n

AGNC Investment (AGNC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to US$9.00 from US$10.00.<\/p>\n

AGNC Investment (AGNC)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$10.00 from US$12.00.<\/p>\n

AGNC Investment (AGNC)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$10.00 from US$11.00.<\/p>\n

Agnico Eagle Mines (AEM)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$190.00 from US$179.00.<\/p>\n

AgomAb Therapeutics (AGMB)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

AgomAb Therapeutics (AGMB)<\/strong> \u2014 Johnson Rice maintained its Buy rating.<\/p>\n

Agree Realty (ADC)<\/strong> \u2014 Baird maintained its Outperform rating and lowered its price target to US$76.00 from US$77.00.<\/p>\n

Agree Realty (ADC)<\/strong> \u2014 BNP Paribas Exane maintained its Neutral rating and lowered its price target to US$74.00 from US$84.00.<\/p>\n

Agree Realty (ADC)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$76.50 from US$81.50.<\/p>\n

AIR Global (AIIR)<\/strong> \u2014 Roth Capital initiated coverage with a Buy rating and set a US$11.50 price target.<\/p>\n

Akamai Technologies (AKAM)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$120.00 from US$158.00.<\/p>\n

Align Technology (ALGN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$205.00 from US$235.00.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to US$48.00 from US$56.00.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 Deutsche Bank set a US$56.00 price target.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 Evercore ISI set a US$40.00 price target.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$44.00 from US$43.00.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$52.00 from US$54.00.<\/p>\n

Ameren (AEE)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$109.00 from US$108.00.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$130.00 from US$128.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$400.00 from US$380.00.<\/p>\n

Amphenol (APH)<\/strong> \u2014 Erste Group initiated coverage with a Buy rating.<\/p>\n

A. O. Smith (AOS)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$72.00 from US$75.00.<\/p>\n

AppFolio (APPF)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$255.00 from US$233.00.<\/p>\n

Apple (AAPL)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating.<\/p>\n

Apple Hospitality REIT (APLE)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$17.00 from US$16.00.<\/p>\n

Applied Digital (APLD)<\/strong> \u2014 Roth Capital resumed coverage with a Buy rating and set a US$35.00 price target.<\/p>\n

Arcus Biosciences (RCUS)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Arcus Biosciences (RCUS)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$41.00 from US$40.00.<\/p>\n

Arcus Biosciences (RCUS)<\/strong> \u2014 Wedbush maintained its Outperform rating and raised its price target to US$49.00 from US$43.00.<\/p>\n

Atlantic Union Bankshares (AUB)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$45.00 from US$47.00.<\/p>\n

Atlantic Union Bankshares (AUB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$43.00 from US$44.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$250.00 from US$185.00.<\/p>\n

Atmos Energy (ATO)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$182.00 from US$179.00.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and raised its price target to US$68.00 from US$52.00.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 UBS downgraded the stock to Sell from Buy.<\/p>\n

Aurinia Pharmaceuticals (AUPH)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$18.00 from US$17.00.<\/p>\n

Bancorp (TBBK)<\/strong> \u2014 Stephens maintained its Equal Weight rating and set a US$59.00 price target.<\/p>\n

Barrick Mining (B)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$55.00 from US$52.00.<\/p>\n

BBB Foods (TBBB)<\/strong> \u2014 UBS maintained its Buy rating and set a US$69.00 price target.<\/p>\n

BETA Technologies (BETA)<\/strong> \u2014 Needham maintained its Buy rating and set a US$34.00 price target.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$250.00 from US$225.00.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$122.00 from US$124.00.<\/p>\n

Blackstone (BX)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and set a US$130.00 price target.<\/p>\n

Block (XYZ)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and set a US$95.00 price target.<\/p>\n

Bloom Energy (BE)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and set a US$260.00 price target.<\/p>\n

BOK Financial (BOKF)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$141.00 from US$148.00.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Citigroup downgraded the stock to Neutral from Buy and lowered its price target to US$47.50 from US$48.00.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Mizuho set a US$47.50 price target.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Raymond James downgraded the stock to Market Perform from Outperform.<\/p>\n

BridgeBio Oncology Therapeutics (BBOT)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$13.00.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$87.00 from US$97.00.<\/p>\n

Brinker International (EAT)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$270.00 from US$280.00.<\/p>\n

CACI International (CACI)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$785.00 from US$675.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$238.00 from US$237.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and raised its price target to US$225.00 from US$219.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$241.00 from US$227.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$269.00 from US$260.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$250.00 from US$242.00.<\/p>\n

Casella Waste Systems (CWST)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$99.00 from US$91.00.<\/p>\n

Casella Waste Systems (CWST)<\/strong> \u2014 UBS downgraded the stock to Neutral from Buy and lowered its price target to US$95.00 from US$122.00.<\/p>\n

CAVA Group (CAVA)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$78.00 from US$85.00.<\/p>\n

Celcuity (CELC)<\/strong> \u2014 TD Cowen maintained its Buy rating and set a US$145.00 price target.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$39.00 from US$38.00.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and set a US$300.00 price target.<\/p>\n

Chagee (CHA)<\/strong> \u2014 Jefferies upgraded the stock to Buy from Hold and set a US$14.90 price target.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$132.00 from US$141.00.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to US$110.00 from US$105.00.<\/p>\n

Chilwa Minerals (CHWM)<\/strong> \u2014 Maxim Group set a US$11.00 price target.<\/p>\n

Chipotle Mexican Grill (CMG)<\/strong> \u2014 TD Cowen downgraded the stock to Hold from Buy and lowered its price target to US$32.00 from US$44.00.<\/p>\n

Chipotle Mexican Grill (CMG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$40.00 from US$45.00.<\/p>\n

Choice Hotels International (CHH)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$121.00 from US$119.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and set a US$333.00 price target.<\/p>\n

Chubb (CB)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Churchill Downs (CHDN)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$115.00 from US$124.00.<\/p>\n

Circle Internet Group (CRCL)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$134.00 from US$130.00.<\/p>\n

Cirrus Logic (CRUS)<\/strong> \u2014 Barclays downgraded the stock to Underweight from Equal Weight and set a US$95.00 price target.<\/p>\n

Cirrus Logic (CRUS)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$170.00 from US$200.00.<\/p>\n

Clean Harbors (CLH)<\/strong> \u2014 UBS upgraded the stock to Buy from Neutral and raised its price target to US$375.00 from US$325.00.<\/p>\n

Clean Harbors (CLH)<\/strong> \u2014 William Blair downgraded the stock to Neutral from Outperform.<\/p>\n

Clearway Energy (CWEN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$52.00 from US$58.00.<\/p>\n

Clearway Energy (CWEN)<\/strong> \u2014 UBS set a US$38.00 price target.<\/p>\n

CMS Energy (CMS)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$73.00 from US$77.00.<\/p>\n

Coinbase Global (COIN)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$205.00 from US$200.00.<\/p>\n

Commerce Bancshares (CBSH)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$60.50 from US$63.00.<\/p>\n

Commerce Bancshares (CBSH)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$62.00 from US$64.00.<\/p>\n

Compass (COMP)<\/strong> \u2014 Zelman & Associates changed its rating to Outperform from Buy.<\/p>\n

Corebridge Financial (CRBG)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$40.00 from US$38.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$124.00 from US$153.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$165.00 from US$170.00.<\/p>\n

Costco Wholesale (COST)<\/strong> \u2014 CICC Research initiated coverage with an Outperform rating and set a US$1,050.00 price target.<\/p>\n

Crown (CCK)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Crown (CCK)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

Cytosorbents (CTSO)<\/strong> \u2014 WBB Securities initiated coverage with a Speculative Buy rating and set a US$9.50 price target.<\/p>\n

DaVita (DVA)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 Piper Sandler upgraded the stock to Overweight from Neutral and lowered its price target to US$126.00 from US$142.00.<\/p>\n

Dime Community Bancshares (DCOM)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$49.00 from US$47.00.<\/p>\n

Dime Community Bancshares (DCOM)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$47.00 from US$45.00.<\/p>\n

DoorDash (DASH)<\/strong> \u2014 BTIG Research maintained its Buy rating and set a US$225.00 price target.<\/p>\n

DTE Energy (DTE)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$139.00 from US$141.00.<\/p>\n

DT Midstream (DTM)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$164.00 from US$170.00.<\/p>\n

Duke Energy (DUK)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$128.00 from US$127.00.<\/p>\n

Duos Technologies Group (DUOT)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and set a US$24.00 price target.<\/p>\n

Dutch Bros (BROS)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$55.00 from US$59.00.<\/p>\n

Dutch Bros (BROS)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$55.00 from US$70.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$73.00 from US$62.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$70.00 from US$60.00.<\/p>\n

East West Bancorp (EWBC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$168.00 from US$164.00.<\/p>\n

East West Bancorp (EWBC)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$153.00 from US$150.00.<\/p>\n

eBay (EBAY)<\/strong> \u2014 Erste Group initiated coverage with a Buy rating.<\/p>\n

Edison International (EIX)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$62.00 from US$60.00.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 Deutsche Bank maintained its Hold rating and set a US$105.00 price target.<\/p>\n

Eli Lilly and Company (LLY)<\/strong> \u2014 Leerink Partners maintained its Outperform rating and raised its price target to US$1,316.00 from US$1,309.00.<\/p>\n

Energy Vault (NRGV)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$28.00 from US$37.00.<\/p>\n

Entergy (ETR)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$101.00 from US$98.00.<\/p>\n

Equifax (EFX)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and raised its price target to US$175.00 from US$160.00.<\/p>\n

Equifax (EFX)<\/strong> \u2014 Deutsche Bank maintained its Buy rating and set a US$201.00 price target.<\/p>\n

Equifax (EFX)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$210.00 from US$190.00.<\/p>\n

Equifax (EFX)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$217.00 from US$235.00.<\/p>\n

Equifax (EFX)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

Equity Lifestyle Properties (ELS)<\/strong> \u2014 Baird maintained its Outperform rating and lowered its price target to US$71.00 from US$74.00.<\/p>\n

ESAB (ESAB)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$110.00 from US$135.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Needham maintained its Buy rating and lowered its price target to US$54.00 from US$55.00.<\/p>\n

Exelon (EXC)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$49.00 from US$50.00.<\/p>\n

Fabrinet (FN)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$600.00 from US$850.00.<\/p>\n

Fastenal (FAST)<\/strong> \u2014 Argus maintained its Buy rating and raised its price target to US$59.00 from US$55.00.<\/p>\n

Fidelity National Financial (FNF)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to US$50.00 from US$55.00.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 Evercore ISI upgraded the stock to Outperform from In-line and set a US$60.00 price target.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$59.00 from US$61.00.<\/p>\n

FirstEnergy (FE)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$50.00 from US$49.00.<\/p>\n

First United (FUNC)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n

First United (FUNC)<\/strong> \u2014 UBS upgraded the stock to Buy.<\/p>\n

First Watch Restaurant Group (FWRG)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

F.N.B. (FNB)<\/strong> \u2014 Raymond James set a US$20.00 price target.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Arete downgraded the stock to Sell from Buy and set a US$117.00 price target.<\/p>\n

Freshpet (FRPT)<\/strong> \u2014 Deutsche Bank set a US$67.00 price target.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 BNP Paribas Exane maintained its Underperform rating and lowered its price target to US$280.00 from US$305.00.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 Deutsche Bank maintained its Buy rating and set a US$378.00 price target.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 Guggenheim set a US$380.00 price target.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 H.C. Wainwright set a US$375.00 price target.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$375.00 from US$400.00.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$375.00 from US$400.00.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$375.00 from US$400.00.<\/p>\n

GE Aerospace (GE)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$400.00 from US$430.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$105.00 from US$110.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 Deutsche Bank set a US$98.00 price target.<\/p>\n

General Motors (GM)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$96.00 from US$112.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$95.00 from US$101.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$98.00 from US$102.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 TD Cowen maintained its Buy rating and set a US$132.00 price target.<\/p>\n

General Motors (GM)<\/strong> \u2014 UBS maintained its Buy rating and set a US$109.00 price target.<\/p>\n

Genuine Parts (GPC)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

GFL Environmental (GFL)<\/strong> \u2014 JPMorgan maintained its Underweight rating and raised its price target to US$42.00 from US$41.00.<\/p>\n

Halliburton (HAL)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$51.00 from US$53.00.<\/p>\n

Halliburton (HAL)<\/strong> \u2014 Jefferies maintained its Buy rating and raised its price target to US$48.00 from US$47.00.<\/p>\n

Halliburton (HAL)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$46.00 from US$45.00.<\/p>\n

Hancock Whitney (HWC)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$79.00 from US$80.00.<\/p>\n

Hancock Whitney (HWC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$88.00 from US$87.00.<\/p>\n

Hancock Whitney (HWC)<\/strong> \u2014 Raymond James maintained its Strong Buy rating.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating and raised its price target to US$127.00 from US$116.00.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 Roth Capital maintained its Buy rating.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 UBS set a US$125.00 price target.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to US$100.00 from US$90.00.<\/p>\n

H. B. Fuller (FUL)<\/strong> \u2014 UBS maintained its Neutral rating and set a US$55.00 price target.<\/p>\n

HealthEquity (HQY)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$125.00 from US$105.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$387.00 from US$365.00.<\/p>\n

Home Bancorp (HBCP)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$64.00 from US$71.00.<\/p>\n

Home Bancorp (HBCP)<\/strong> \u2014 Raymond James set a US$66.00 price target.<\/p>\n

Hyatt Hotels (H)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$207.00 from US$209.00.<\/p>\n

IDACORP (IDA)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$144.00 from US$143.00.<\/p>\n

IDEX (IEX)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$275.00 from US$270.00.<\/p>\n

Incyte (INCY)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$140.00 from US$138.00.<\/p>\n

Insmed (INSM)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$213.00 from US$218.00.<\/p>\n

Intel (INTC)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$105.00 from US$115.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Baird maintained its Outperform rating and raised its price target to US$550.00 from US$513.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$500.00 from US$485.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 BTIG Research maintained its Buy rating and set a US$454.00 price target.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Erste Group upgraded the stock to Buy from Hold.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$475.00 from US$450.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Leerink Partners set a US$503.00 price target.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$400.00 from US$415.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and set a US$500.00 price target.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Raymond James maintained its Outperform rating and set a US$480.00 price target.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$550.00 from US$575.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$486.00 from US$487.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Jazz Pharmaceuticals (JAZZ)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$314.00 from US$322.00.<\/p>\n

JFrog (FROG)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$115.00 from US$110.00.<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 Erste Group downgraded the stock to Hold from Buy.<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 Johnson Rice downgraded the stock to Hold from Buy.<\/p>\n

Kazia Therapeutics (KZIA)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating and set a US$35.00 price target.<\/p>\n

KeyCorp (KEY)<\/strong> \u2014 D.A. Davidson maintained its Buy rating and raised its price target to US$27.00 from US$26.00.<\/p>\n

KeyCorp (KEY)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$24.00 from US$25.00.<\/p>\n

Kinetik (KNTK)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$67.00 from US$70.00.<\/p>\n

Knowles (KN)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$35.00 from US$40.00.<\/p>\n

Kroger (KR)<\/strong> \u2014 Deutsche Bank maintained its Buy rating and set a US$70.00 price target.<\/p>\n

Kroger (KR)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to US$68.00 from US$66.00.<\/p>\n

Kroger (KR)<\/strong> \u2014 UBS maintained its Outperform rating and set a US$66.00 price target.<\/p>\n

Kroger (KR)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to US$60.00 from US$58.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$51.00 from US$63.00.<\/p>\n

Lyft (LYFT)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$26.00 from US$30.00.<\/p>\n

Magna International (MGA)<\/strong> \u2014 CIBC downgraded the stock to Neutral from Outperformer and lowered its price target to US$70.00 from US$78.00.<\/p>\n

Marriott International (MAR)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$406.00 from US$388.00.<\/p>\n

Mercantile Bank (MBWM)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$65.00 from US$64.00.<\/p>\n

MetLife (MET)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$114.00 from US$110.00.<\/p>\n

MGE Energy (MGEE)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$72.00 from US$71.00.<\/p>\n

Microbot Medical (MBOT)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and set a US$12.00 price target.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Guggenheim maintained its Buy rating and set a US$586.00 price target.<\/p>\n

Mid-America Apartment Communities (MAA)<\/strong> \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to US$125.00 from US$142.00.<\/p>\n

MiNK Therapeutics (INKT)<\/strong> \u2014 B. Riley Securities maintained its Buy rating and raised its price target to US$50.00 from US$43.00.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$145.00 from US$140.00.<\/p>\n

Mission Produce (AVO)<\/strong> \u2014 Santander initiated coverage with an Outperform rating.<\/p>\n

Mobileye Global (MBLY)<\/strong> \u2014 RBC Capital Markets downgraded the stock to Underperform from Sector Perform and lowered its price target to US$5.00 from US$7.00.<\/p>\n

MSCI (MSCI)<\/strong> \u2014 Jefferies maintained its Buy rating and set a US$680.00 price target.<\/p>\n

MSCI (MSCI)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$710.00 from US$685.00.<\/p>\n

MSCI (MSCI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$671.00 from US$662.00.<\/p>\n

MSCI (MSCI)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and set a US$655.00 price target.<\/p>\n

MSCI (MSCI)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$720.00 from US$685.00.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Nebius Group (NBIS)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$185.00 from US$237.00.<\/p>\n

Neptune Insurance (NP)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$33.00 from US$31.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to US$65.00 from US$70.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Bernstein maintained its Outperform rating and lowered its price target to US$80.00 from US$95.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 BofA Securities maintained its Buy rating and lowered its price target to US$90.00 from US$105.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Canaccord Genuity set a US$110.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Citizens JMP maintained its Market Perform rating.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Deutsche Bank set a US$93.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Evercore ISI maintained its Outperform rating and set a US$90.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Goldman Sachs set a US$84.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Guggenheim maintained its Buy rating and lowered its price target to US$78.00 from US$80.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$81.00 from US$85.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Moffett Nathanson maintained its Buy rating and set a US$90.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$77.00 from US$80.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Needham downgraded the stock to Hold from Buy.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$80.00 from US$85.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$78.00 from US$85.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Pivotal Research maintained its Hold rating and set a US$65.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Rosenblatt maintained its Neutral rating and lowered its price target to US$71.00 from US$75.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 TD Cowen maintained its Buy rating and set a US$100.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 UBS maintained its Reduce rating and set a US$90.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 William Blair maintained its Outperform rating.<\/p>\n

NetSol Technologies (NTWK)<\/strong> \u2014 Noble Capital Markets initiated coverage with an Outperform rating and set a US$9.00 price target.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 Bernstein maintained its Outperform rating and set a US$108.00 price target.<\/p>\n

Nextpower (NXT)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to US$114.00 from US$132.00.<\/p>\n

Nexxen International (NEXN)<\/strong> \u2014 BTIG Research maintained its Buy rating and set a US$13.00 price target.<\/p>\n

Nicolet Bankshares (NIC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$196.00 from US$194.00.<\/p>\n

NiSource (NI)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 Baird upgraded the stock to Outperform from Neutral and raised its price target to US$675.00 from US$550.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating and raised its price target to US$600.00 from US$540.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to US$640.00 from US$612.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$765.00 from US$745.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$550.00 from US$525.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 UBS maintained its Buy rating and set a US$698.00 price target.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$144.00 from US$159.00.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Raymond James maintained its Strong Buy rating and set a US$152.00 price target.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 UBS maintained its Strong Buy rating and set a US$152.00 price target.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Williams Trading set a US$165.00 price target.<\/p>\n

NuScale Power (SMR)<\/strong> \u2014 Citigroup maintained its Sell rating.<\/p>\n

Oculis (OCS)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

OGE Energy (OGE)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$47.00 from US$46.00.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$78.00 from US$79.00.<\/p>\n

ONEOK (OKE)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$96.00 from US$90.00.<\/p>\n

onsemi (ON)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$120.00 from US$150.00.<\/p>\n

Pacific Gas & Electric (PCG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$21.00 from US$20.00.<\/p>\n

Palisade Bio (PALI)<\/strong> \u2014 Oppenheimer maintained its Outperform rating.<\/p>\n

Park Hotels & Resorts (PK)<\/strong> \u2014 JPMorgan maintained its Underweight rating and raised its price target to US$16.00 from US$14.00.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 Citigroup maintained its Market Perform rating.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 UBS downgraded the stock to Sell.<\/p>\n

Pentair (PNR)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$84.00 from US$94.00.<\/p>\n

Phathom Pharmaceuticals (PHAT)<\/strong> \u2014 Craig Hallum maintained its Buy rating and set a US$15.00 price target.<\/p>\n

Pinnacle West Capital (PNW)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$91.00 from US$89.00.<\/p>\n

Power Integrations (POWI)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$70.00 from US$85.00.<\/p>\n

PPL (PPL)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$40.00 from US$39.00.<\/p>\n

Prologis (PLD)<\/strong> \u2014 Raymond James upgraded the stock to Outperform from Market Perform and set a US$163.00 price target.<\/p>\n

Protagonist Therapeutics (PTGX)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$160.00 from US$155.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$112.00 from US$114.00.<\/p>\n

Public Service Enterprise Group (PEG)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$85.00 from US$88.00.<\/p>\n

Qualcomm (QCOM)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$185.00 from US$160.00.<\/p>\n

QumulusAI (QMLS)<\/strong> \u2014 B. Riley Securities initiated coverage with a Buy rating and set a US$11.00 price target.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 JonesTrading maintained its Buy rating and raised its price target to US$82.00 from US$50.00.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$50.00 from US$51.00.<\/p>\n

Real REMAX Group (REAX)<\/strong> \u2014 Zelman & Associates downgraded the stock to Neutral from Outperform.<\/p>\n

Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$980.00 from US$960.00.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and set a US$32.00 price target.<\/p>\n

Reinsurance Group of America (RGA)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$250.00 from US$235.00.<\/p>\n

Revolution Medicines (RVMD)<\/strong> \u2014 TD Cowen maintained its Buy rating and set a US$250.00 price target.<\/p>\n

RLI (RLI)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating.<\/p>\n

RLI (RLI)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and raised its price target to US$53.00 from US$51.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$126.00 from US$123.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Rosenblatt initiated coverage with a Buy rating and set a US$135.00 price target.<\/p>\n

RTX (RTX)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$235.00 from US$223.00.<\/p>\n

RTX (RTX)<\/strong> \u2014 UBS maintained its Neutral rating and set a US$212.00 price target.<\/p>\n

Ryman Hospitality Properties (RHP)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$138.00 from US$129.00.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and set a US$300.00 price target.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 D.A. Davidson maintained its Neutral rating and raised its price target to US$250.00 from US$225.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to US$1,200.00 from US$1,150.00.<\/p>\n

Selective Insurance Group (SIGI)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$180.00 from US$130.00.<\/p>\n

Shake Shack (SHAK)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to US$70.00 from US$65.00.<\/p>\n

Silence Therapeutics (SLN)<\/strong> \u2014 H.C. Wainwright downgraded the stock to Neutral from Buy and lowered its price target to US$20.00 from US$75.00.<\/p>\n

Six Flags Entertainment (FUN)<\/strong> \u2014 Guggenheim maintained its Buy rating and lowered its price target to US$17.00 from US$28.00.<\/p>\n

Six Flags Entertainment (FUN)<\/strong> \u2014 Mizuho set a US$5.00 price target.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$90.00 from US$65.00.<\/p>\n

SmartFinancial (SMBK)<\/strong> \u2014 Raymond James downgraded the stock to Outperform from Strong Buy and lowered its price target to US$56.00 from US$58.00.<\/p>\n

SM Energy (SM)<\/strong> \u2014 Raymond James maintained its Outperform rating and set a US$50.00 price target.<\/p>\n

SolarEdge Technologies (SEDG)<\/strong> \u2014 BMO Capital Markets maintained its Underperform rating and lowered its price target to US$28.00 from US$31.00.<\/p>\n

Solaris Energy Infrastructure (SEI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$102.00 from US$90.00.<\/p>\n

Solstice Advanced Materials (SOLS)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and set a US$87.00 price target.<\/p>\n

Southern (SO)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating.<\/p>\n

Southern (SO)<\/strong> \u2014 D.A. Davidson set a US$98.00 price target.<\/p>\n

Southern (SO)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$84.00 from US$85.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Barclays maintained its Overweight rating and set a US$300.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Bernstein maintained its Outperform rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and set a US$245.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$500.00 from US$240.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 KeyCorp maintained its Sector Weight rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Mizuho set a US$205.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Needham maintained its Buy rating and set a US$250.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Piper Sandler maintained its Neutral rating.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Pivotal Research set a US$260.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$176.00 from US$173.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$224.00 from US$200.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$274.00 from US$214.00.<\/p>\n

Sphere Entertainment (SPHR)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$158.00 from US$182.00.<\/p>\n

SPX Technologies (SPXC)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$265.00 from US$270.00.<\/p>\n

Spyglass Pharma (SGP)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and set a US$37.00 price target.<\/p>\n

Starbucks (SBUX)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$120.00 from US$125.00.<\/p>\n

Steel Dynamics (STLD)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$271.00 from US$257.00.<\/p>\n

Stem (STEM)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$5.00 from US$8.00.<\/p>\n

Sunstone Hotel Investors (SHO)<\/strong> \u2014 JPMorgan maintained its Underweight rating and raised its price target to US$11.00 from US$10.00.<\/p>\n

Sweetgreen (SG)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$9.00 from US$6.00.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$94.00 from US$93.00.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 Evercore ISI downgraded the stock to In-line from Outperform and set a US$78.00 price target.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$77.00 from US$74.00.<\/p>\n

Talen Energy (TLN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$504.00 from US$514.00.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$328.00 from US$303.00.<\/p>\n

Telix Pharmaceuticals (TLX)<\/strong> \u2014 Wedbush maintained its Outperform rating and set a US$22.00 price target.<\/p>\n

Terrestrial Energy (IMSR)<\/strong> \u2014 Lake Street initiated coverage with a Buy rating and set a US$15.00 price target.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

TKO Group (TKO)<\/strong> \u2014 BTIG Research maintained its Buy rating and set a US$237.00 price target.<\/p>\n

Transcat (TRNS)<\/strong> \u2014 Northland Capital upgraded the stock to Outperform from Market Perform and set a US$95.00 price target.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 UBS maintained its Neutral rating and set a US$83.00 price target.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Twilio (TWLO)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$325.00 from US$275.00.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 Evercore ISI maintained its Outperform rating and set a US$160.00 price target.<\/p>\n

United Community Banks (UCB)<\/strong> \u2014 Stephens maintained its Overweight rating and raised its price target to US$42.00 from US$41.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Bernstein maintained its Outperform rating and lowered its price target to US$127.00 from US$131.00.<\/p>\n

Valvoline (VVV)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$46.00 from US$49.00.<\/p>\n

Vicor (VICR)<\/strong> \u2014 Roth Capital set a US$360.00 price target.<\/p>\n

Vistra (VST)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$226.00 from US$227.00.<\/p>\n

Vistra (VST)<\/strong> \u2014 Raymond James maintained its Strong Buy rating and set a US$176.00 price target.<\/p>\n

Vistra (VST)<\/strong> \u2014 UBS set a US$176.00 price target.<\/p>\n

Vor Biopharma (VOR)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$85.00 from US$90.00.<\/p>\n

Western Digital (WDC)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to US$800.00 from US$720.00.<\/p>\n

Western Midstream Partners (WES)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$52.00 from US$55.00.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$186.00 from US$195.00.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 Raymond James set a US$165.00 price target.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$174.00 from US$173.00.<\/p>\n

Wolfspeed (WOLF)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$25.00 from US$30.00.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$85.00 from US$83.00.<\/p>\n

Xencor (XNCR)<\/strong> \u2014 Wedbush maintained its Outperform rating and set a US$30.00 price target.<\/p>\n

X-Energy (XE)<\/strong> \u2014 UBS maintained its Buy rating and set a US$18.00 price target.<\/p>\n

Xilio Therapeutics (XLO)<\/strong> \u2014 Raymond James initiated coverage with an Outperform rating and set a US$16.00 price target.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 Deutsche Bank maintained its Hold rating and set a US$167.00 price target.<\/p>\n

Zions Bancorporation (ZION)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and raised its price target to US$69.00 from US$68.00.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 BTIG Research maintained its Buy rating and set a US$125.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and set a US$104.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 Oppenheimer upgraded the stock to Outperform from Market Perform and set a US$130.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and set a US$130.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 Rosenblatt maintained its Buy rating and set a US$130.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 UBS maintained its Neutral rating and set a US$112.00 price target.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 D.A. Davidson initiated coverage with a Neutral rating and set a US$215.00 price target.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Today\u2019s analyst updates suggest a selective outlook, with strength in defence, pharmaceuticals and parts of software and financial services. Technology remains…<\/p>\n","protected":false},"author":3,"featured_media":32707,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76497","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUS Analyst Updates: October 21st, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates: October 21st, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today\u2019s analyst updates suggest a selective outlook, with strength in defence, pharmaceuticals and parts of software and financial services. Technology remains…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-21T18:15:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/04\/Netflix-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"842\" \/>\n\t<meta property=\"og:image:height\" content=\"376\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"27 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates: October 21st, 2026\",\"datePublished\":\"2026-10-21T18:15:19+00:00\",\"dateModified\":\"2026-10-21T18:15:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\"},\"wordCount\":6138,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\",\"name\":\"US Analyst Updates: October 21st, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-21T18:15:19+00:00\",\"dateModified\":\"2026-10-21T18:15:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates: October 21st, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates: October 21st, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates: October 21st, 2026","og_description":"Analyst Ratings (USA) Today\u2019s analyst updates suggest a selective outlook, with strength in defence, pharmaceuticals and parts of software and financial services. Technology remains…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-21T18:15:19+00:00","og_image":[{"width":842,"height":376,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/04\/Netflix-logo.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"27 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates: October 21st, 2026","datePublished":"2026-10-21T18:15:19+00:00","dateModified":"2026-10-21T18:15:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/"},"wordCount":6138,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/","name":"US Analyst Updates: October 21st, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-21T18:15:19+00:00","dateModified":"2026-10-21T18:15:19+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-21st-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates: October 21st, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76497"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76497\/revisions"}],"predecessor-version":[{"id":76501,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76497\/revisions\/76501"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/32707"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}